Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
Vertex Pharmaceuticals stock last closed at $396.62, down 1.09% from the previous day, and has decreased 16.62% in one year. It has overperformed other stocks in the Biotechnology industry by 0.36 percentage points. Vertex Pharmaceuticals stock is currently +9.41% from its 52-week low of $362.50, and -23.71% from its 52-week high of $519.88.
There are currently 256.39M VRTX shares outstanding. The market capitalization of VRTX is $101.69B. In the last 24 hours, 1.24M VRTX shares were traded.
How to Buy Vertex Pharmaceuticals Stock
Wondering how to invest in Vertex Pharmaceuticals stock? Here's how.
Decide where to buy Vertex Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Vertex Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Put funds into your brokerage account: Select your method of payment and add your info.
Research Vertex Pharmaceuticals stock: The Vertex Pharmaceuticals ticker symbol is VRTX. Is Vertex Pharmaceuticals stock a good investment? Should you buy shares of VRTX? How do VRTX's underlying business fundamentals look? Do top analysts think Vertex Pharmaceuticals is a good buy? Why has VRTX's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if VRTX is a good stock to buy).
Execute your VRTX purchase: Decide if you will purchase VRTX shares at the current market price or use a limit order to buy VRTX stock at a given price.
Get the latest scoop on your investment in VRTX: Create a watchlist to important updates regarding your position in Vertex Pharmaceuticals stock.
Step 1: Decide where to buy Vertex Pharmaceuticals stock
You will need an online brokerage account to access the NASDAQ market and buy VRTX shares.
A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you are able to invest in VRTX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Vertex Pharmaceuticals stock
After you have selected the best place to buy Vertex Pharmaceuticals stock, it's important to research their stock before you buy, so you can comprehend the risk and opportunity.
Vertex Pharmaceuticals Metrics
VRTX Price
$396.62
1w %
1.94%
1y %
-16.62%
5y %
48.31%
P/E
28.09x
P/B
5.92x
P/S
8.92x
PEG
2.73x
Revenue
$11.42B
Earnings
$3.64B
Fore. Rev. Growth
7.19%
Fore. Earn. Growth
10.3%
Market Cap
$101.69B
Next Earnings
Oct 29, 2025
Next Dividend
N/A
Fundamentals of VRTX
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in less time.
VRTX earnings of $4.39B is not sufficient to cover its interest payments.
VRTX profit margin has gone up from -4.7% to 31.9% in the past year.
VRTX's operating cash flow of $3.85B allows it to safely service it's debt of $1.53B.
VRTX has a low debt to equity ratio of 0.4.
There are more short-term assets than short-term liabilities on the VRTX balance sheet.
There are more short-term assets than long-term liabilities on the VRTX balance sheet.
Cons:
Total VRTX debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy VRTX stock
Out of 16 sell side analysts who give ratings on VRTX, the consensus analyst rating on VRTX is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent VRTX Analyst Forecasts
Brian Abrahams, a bottom 7% analyst from RBC Capital maintains VRTX with a hold rating and lowers their VRTX price target from $430.00 to $405.00, on Aug 5, 2025.
Colin Bristow, a bottom 5% analyst from UBS maintains VRTX with a strong buy rating and lowers their VRTX price target from $582.00 to $553.00, on Aug 5, 2025.
Evan Seigerman, a bottom 11% analyst from BMO Capital maintains VRTX with a buy rating and lowers their VRTX price target from $557.00 to $530.00, on Aug 5, 2025.
Carter Gould, a top 15% analyst from Cantor Fitzgerald maintains VRTX with a strong buy rating and lowers their VRTX price target from $535.00 to $485.00, on Aug 5, 2025.
Paul Matteis, a bottom 5% analyst from Stifel Nicolaus maintains VRTX with a hold rating and lowers their VRTX price target from $494.00 to $455.00, on Aug 5, 2025.
Last year, VRTX earnings were $3.64B. In the last five year, VRTX's earnings have gone up by 11.98% per year. This was faster than the Biotechnology industry average of 8.98%.
Last year, VRTX revenue was $11.42B. Over the past five year, VRTX's revenue has grown by 16.15% per year. This was slower than the Biotechnology industry average of 66.23%.
No, Vertex Pharmaceuticals doesn't provide an income stream by paying out dividends.
VRTX Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your VRTX purchase
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are mostly the best for newer investors.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you want additional help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Vertex Pharmaceuticals share?
As of Sep 3, 2025, it costs $396.62 to buy one share of Vertex Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.252 shares of VRTX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.